For thousands of individuals, the journey toward better health following significant weight loss often culminates in reconstructive body contouring surgery. Among these procedures, the panniculectomy—the surgical removal of excess, hanging skin and adipose tissue from the lower abdomen—is considered a vital functional intervention. It alleviates chronic rashes, persistent infections, and significant mobility limitations. However, as the medical community continues to navigate the long-term aftermath of the global pandemic, a critical new safety concern has emerged.
A recent study published in the November issue of Plastic and Reconstructive Surgery—the official journal of the American Society of Plastic Surgeons (ASPS)—indicates that patients with a documented history of COVID-19 may face a substantially higher risk of venous thromboembolism (VTE) following a panniculectomy. This finding prompts a necessary re-evaluation of how surgeons assess risk and manage post-operative care for a growing segment of the population.
The Core Findings: A Statistically Significant Correlation
The research, led by Mary Newland, BS, a medical student at Penn State College of Medicine, analyzed national hospital data from 7,114 patients who underwent functional panniculectomy between 2017 and 2023. The objective was to determine whether the biological footprint left by a COVID-19 infection translates into a measurable increase in surgical risk.
The results are stark. When comparing patients who had recovered from COVID-19 against those who had never contracted the virus, the researchers found that the former group experienced VTE at a rate of 4.9%, compared to just 2.5% in the non-COVID cohort. This represents a significant increase in risk that persists even when accounting for other traditional comorbidities, such as heart, lung, and vascular disease, which were distributed evenly across both groups.
The study serves as a warning bell for plastic and reconstructive surgeons: a patient’s medical history now requires a deeper investigation into their COVID-19 status, as the lingering effects of the virus on the body’s clotting mechanism may create a "hidden" risk factor that traditional scoring systems might overlook.
A Chronological Shift in Surgical Risk
To understand the significance of these findings, it is helpful to look at the timeline of the data collection, which spans the pre-pandemic and pandemic eras.
The Pre-Pandemic Baseline (2017–March 2020)
Before the emergence of COVID-19, the risk profile for a patient undergoing a panniculectomy was well-understood and governed by standard protocols, most notably the Caprini Risk Assessment Model. During this period, surgeons evaluated patients based on age, BMI, underlying health conditions, and duration of surgery. VTE rates were relatively stable, with the study reporting a 3.2% incidence rate for patients undergoing surgery during this timeframe.
The Pandemic Era (March 2020–2023)
As the pandemic took hold, medical professionals began observing a systemic phenomenon: COVID-19 was not merely a respiratory illness; it was a vascular one. The virus induced a hypercoagulable state—a condition where the blood is significantly more prone to clotting.
When researchers examined the post-pandemic cohort of 4,099 patients, they initially observed a stable overall VTE rate of 3.0%. However, this top-level data masked a more nuanced reality. Once the researchers filtered the data to isolate the 790 patients who had a history of COVID-19, the true impact of the virus became visible. The divergence between those with and without a history of the virus suggests that the pandemic-era surgical landscape is fundamentally different from what existed prior to 2020.
Supporting Data: Understanding the Mechanism of Risk
Venous thromboembolism, which encompasses deep vein thrombosis (DVT) and the potentially fatal pulmonary embolism (PE), occurs when a blood clot forms in the deep veins, usually in the legs, and travels to the lungs.
The study’s data suggests that the hypercoagulability triggered by COVID-19 does not necessarily disappear once the patient recovers from the initial infection. Instead, it may leave behind an "activated" clotting system that reacts more aggressively to the trauma of surgery.
Risk Factors and Comparisons
The study highlights that while traditional risk factors—such as diabetes, hypertension, or smoking—remained consistent across both groups, the COVID-19 variable acted as an independent predictor of adverse outcomes. The fact that the 4.9% VTE rate in COVID-positive patients was significantly higher than the 2.5% rate in their counterparts suggests that the viral infection acts as an additional, latent stressor on the vascular system.
Standard protocols for these patients included the use of prophylactic anticoagulants (blood thinners) based on their Caprini scores. Yet, despite these precautions, the COVID-19 group remained at a higher risk. This indicates that current standard-of-care protocols may need to be enhanced for this specific demographic.
Official Responses and Clinical Perspectives
Lead author Mary Newland emphasizes that these findings have immediate clinical implications. "Our results demonstrate a significant increase in the incidence of VTE among panniculectomy patients with a history of COVID-19," she notes. "This may have implications for assessment and prevention of surgical risks of body contouring surgery after major weight loss."
The medical community is now tasked with determining how to adapt. If a patient’s history of COVID-19 makes them a high-risk candidate for VTE, surgeons may need to implement more aggressive anticoagulant regimens, longer monitoring periods, or even delay elective procedures until the patient’s inflammatory markers have returned to a more stable baseline.
The authors conclude that their work "shows the emergence of a new patient population who may be more susceptible to postoperative VTEs." They advocate for larger, multi-center studies to confirm these findings and to establish updated guidelines for the safe management of post-COVID patients seeking reconstructive surgery.
Implications for the Future of Body Contouring
The implications of this research extend far beyond the operating room and into the pre-operative planning phase. For both patients and providers, this study serves as a catalyst for a more comprehensive approach to informed consent and risk stratification.
1. Updated Pre-Operative Screening
Surgeons must now integrate a detailed COVID-19 history into their standard intake procedures. This includes not just asking if a patient had the virus, but also the severity of their symptoms, the time elapsed since infection, and whether they suffered from any lingering vascular or respiratory complications.
2. Tailored Prophylaxis
If the risk of VTE is higher in post-COVID patients, the use of standard mechanical prophylaxis (such as compression stockings and sequential compression devices) combined with chemical prophylaxis (blood thinners) may need to be adjusted in duration and dosage.
3. Patient Education
Patients who have recovered from COVID-19 and are considering a panniculectomy must be made aware of this elevated risk. Transparency in the consultation process is vital, allowing patients to weigh the benefits of the procedure against the potential for post-operative clotting complications.
4. A Call for Further Research
While this study provides a vital piece of the puzzle, the authors are the first to admit that more work is needed. Future research must look at whether the severity of the initial COVID-19 infection—or the number of times a patient has been infected—correlates with the magnitude of VTE risk. Additionally, investigating the effectiveness of specific anticoagulant protocols for this sub-population will be the next logical step in ensuring patient safety.
Conclusion: Adapting to a Changing Landscape
The field of plastic and reconstructive surgery has always been at the forefront of combining aesthetic improvement with functional restoration. As the world continues to move past the immediate crisis of the pandemic, the long-term medical ripples of COVID-19 continue to surface.
The findings published in Plastic and Reconstructive Surgery remind us that medicine is an evolving discipline. What was considered a standard risk profile just a few years ago must now be viewed through the lens of a population that has experienced a global, systemic viral event. By identifying these increased risks, the surgical community can proactively adjust its practices, ensuring that patients seeking life-changing body contouring surgery can continue to do so with the highest possible standards of safety and care.
For those interested in the full scope of the research, the study "Incidence of Postoperative Venous Thromboembolism following Panniculectomy in Patients with History of COVID-19" (doi: 10.1097/PRS.0000000000012202) is available in the November issue of Plastic and Reconstructive Surgery, published by Wolters Kluwer.
About the Author
